clinical outcome; hepatocellular carcinoma; surgical margin Background/Purpose: Surgical resection for hepatocellular carcinoma (HCC) is regarded as a curable treatment; however, the postoperative recurrence still poses a challenge to surgeons. The effect of surgical margin on long-term outcome is still controversial, although it has been considered as the treatment-related risk factor for recurrence. A precise assessment of the effects of surgical margin on clinical outcome is required to clarify the issue. Methods: A retrospective study was conducted on 407 patients with microscopically complete resection of HCC; they were divided into three groups with surgical margin negative by 1e5 mm (Group A, n Z 156), 6e10 mm (Group B, n Z 109), and wider than 10 mm (Group C, n Z 142). The groups were compared for clinicopathologic characteristics, perioperative features, postoperative recurrence, and long-term outcome. Results: The median follow-up time for all patients was 72.97 months. Recurrence rates were similar among these groups. There was no significant difference in the overall 1-, 3-, and 5-year actual survival rates for the groups on the log-rank test (p Z 0.073). After controlling the independent risks for disease-free survival, there was also no significant difference in the 1-, 3-, and 5-year disease-free survival rates for the groups (p Z 0.354). The patients with wider surgical margin had worse perioperative outcomes; more patients in this group needed blood transfusion (p < 0.001) and more patients suffered from postoperative complications (p Z 0.020). They also had higher in-hospital mortality rate than that of other groups (1.41% vs. 0.64%).
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Introduction
Hepatic resection is now a safe procedure and represents the only potentially curative option for hepatocellular carcinoma (HCC), with a 5-year survival rate of 31.83e59%; 1, 2 however, the long-term survival is still unsatisfactory because of high recurrent rate after hepatic resection.
Plenty of risk factors for HCC recurrence after surgery have been studied. Margin status is an additional factor that has been examined for its effect on disease-free survival (DFS) and overall survival (OS) after surgery; however, its clinical significance remains controversial. Shi et al 3 demonstrated that the 1-, 2-, 3-, and 5-year OS rates for the wide margin group were significantly better than that for the narrow margin group, and indicated that, for macroscopically solitary HCC, a resection margin aiming grossly at 2 cm decreased postoperative recurrence rate efficaciously and safely, and improved survival outcomes when compared with a gross resection margin aiming at 1 cm. Zhou et al 4 reported that the required minimal length of resection margin is 6 mm to achieve 100% micrometastasis clearance in the surrounding liver tissue of HCC, and should be >18.5 mm to obtain 99% micrometastasis clearance in surrounding liver tissue of HCC patients with macroscopic tumor thrombi or macrosatellites. In patients with cirrhosis and a small HCC, anatomic resection obtains better DFS than limited resection without increasing the postoperative risk. 5 On the other hand, Matsue et al 6 reported that limited resection with no margin seems to be the best procedure for patients with tumors close to the major hepatic vessels and with hepatic functions that do not permit wide-margin resections. They indicated that no margin resection for HCC do not negatively affect patient's outcomes. In patients with severely impaired liver function or with tumor close to these large vascular structures, an adequate surgical margin may not be feasible. Poon et al 7 also pointed out that most intrahepatic recurrences were considered to arise from intrahepatic metastasis by means of venous dissemination, which a wide resection could not prevent.
The contradictory results could be contributory to the heterogeneity of these series, in terms of various parameters such as tumor characteristics, activity of the underlying disease, degree of fibrosis of the noncancerous parenchyma, and host factors.
In the viewpoint of liver surgeons, surgical margin is just one of the risk factors in terms of recurrence; complete HCC resection and avoidance of hepatic failure are what they want to achieve most. The objective of this work is to examine the influence of surgical margin status on perioperative and longterm outcomes in patients with resectable HCC.
Materials and methods
Between January 2000 and July 2007, 547 consecutive patients with HCC, all of whom underwent liver resections at Kaohsiung Medical University Hospital and Yuan's Hospital, were recruited for this study. The inclusion criterions for liver surgery were as follows: (1) ChildePugh class (i.e., A or B status); (2) tumor, lymph node, metastasis (TNM) classification stages (i.e., stages I, II, and III-a); (3) patency of main portal and hepatic veins; (4) no presence of an extrahepatic metastasis; (5) no obvious ascites; and (6) the level of bilirubin <2.0 mg/dL. During surgery, accurate intraoperative ultrasonography was performed to detect previously undocumented lesion(s); if more intrahepatic nodules were found or there was identifiable evidence of extrahepatic diffusion, liver resection was not performed. Intraoperative ultrasonography was also used to mark the line of parenchyma transaction on the liver surface to obtain an optimal width of tumor-free margin and avoid/circumvent the major hepatic veins on the transaction plane.
Among the recruited cases, we excluded patients who received or underwent the following treatments or conditions: (1) previous history of liver resection (n Z 20); (2) treatment(s) with microwave ablation (n Z 15) or radiofrequency ablation (n Z 24) during surgery; (3) ruptured HCC (n Z 16); (4) liver resection for recurrent HCC (n Z 2); (5) surgical margins not recorded (n Z 29); (6) surgical margins not free from HCC (n Z 10); and (7) lack of detail medical records (n Z 24). Finally, 407 patients were included in our empirical analysis.
Patients were classified according to the width of the surgical margin, defined as the shortest distance from the edge of the tumor to the line of transaction. By this definition, margin status was then divided into three subgroups: Group A (n Z 156), negative by 1e5 mm; Group B (n Z 109), 6d10 mm; and Group C (n Z 142), wider than 10 mm.
Patients' clinical information was obtained from medical charts, reviewed by junior attending physicians in two hospital departments, using a constructed instrument. The information comprised patients' demographics, clinical variables, histological grades, tumor staging, and perioperative features. The extent of surgical resection was defined according to Couinaud's classification system. Tumors were graded as welldfrom moderately to poorly differentiateddaccording to the World Health Organization (WHO) classification of tumors of the digestive system. Tumors were staged according to the American Joint Committee on Cancer (AJCC) (TNM) classification system.
All patients (except the three patients who died perioperatively) underwent routine and regular follow-up care at our outpatient department and were carefully monitored for pathological recurrence based on serum levels of afetoprotein each month and abdominal ultrasonography once every 3 months. Abdominal contrast-computed tomography (CT) scan or magnetic resonance imaging (MRI) was conducted when a possible recurrent lesion was found in ultrasonographic assessment or levels of serum afetoprotein was increasing continuously.
To make a comparison between clinicopathological features and perioperative treatments, all values were expressed as means with their associated standard deviations. Student t test or one-way analysis of variance (ANOVA) was used for continuous variables, and a Chi-square or Fisher's exact test was used for categorical variables. The prognostic significance of various clinicopathological factors with respect to OS and DFS rates was examined via an application of univariate and multivariate Cox regression analysis techniques. The KaplaneMeier method was first to be employed to understand the association between the three resection groups, and "OS" and "DFS." Multiple Cox regression models were used to explore the association further, while adjusting all other clinical parameters. A p value of <0.05 was considered statistically significant. Data analysis was performed using SPSS software (version 12.0) for Windows XP. Table 1 shows that there was no evidence of significant difference among the three groups with regard to demographic and clinicopathologic factors. The patients in Group A, however, received less advanced histological grading of HCC than those of the other two groups (p < 0.001). Table 2 presents the perioperative features for these patients with various resection margins. Eighty out of 142 patients (56.33%) in Group C received extensive liver resection for the treatment of HCC, which is significantly higher than in case of Group A patients (p < 0.001). More patients in Group C (66/142, 46.48%) needed blood transfusion during operation; it is significantly higher than in other two groups (p Z 0.020). Twenty-two of 142 patients (15.49%) in Group C suffered from postoperative complications, which is statistically the highest among the three groups (p Z 0.042). Three patients died within 30 days of liver resection (a perioperative mortality rate of 0.74%): two of them were encountered in Group C patients (1.41%) and one (0.64%) in Group A patients.
Results
In this study, out of total 407 patients with a median follow-up period of 72.97 months, 220 (54.1%) developed a recurrence. The median time to recurrence was 21.27 months (range, 0.53e67.23 months), with the majority of patients (78/220, 35.5%) recurring within 1 year after liver resection. The 1-, 3-, and 5-year DFS rates were 64.6%, 50.1%, and 45.9%, respectively.
The median survival was 60.23 months, and the overall mortality rate was 37.84%. The 1-, 3-, and 5-year OS rates were 86.7%, 70.8%, and 63.9% respectively. Patients with different surgical margins in Groups A, B, and C had similar overall recurrence rates (58.97%, 54.13%, and 48.59%, respectively), although recurrent rate was slightly higher in patients with surgical margin of 1e5 mm (Group A) than in those with wider margins; however, this difference was not significant (p Z 0.199). In the meanwhile, no significant difference in OS (Group A, 57.73 AE 3.63 months; Group B, 55.35 AE 4.12 months; and Group C, 62.58 AE 3.48 months) and disease-free period (Group A, 29.35 AE 2.76 months; Group B, 35.65 AE 3.46 months; and Group C, 45.74 AE 3.64 months) was found in patients with various surgical margins, regardless of the width of the margins (p Z 0.370 and 0.073, respectively).
To evaluate the possibility of HCC recurrence within 2 years (so-called early recurrence), we found that 186 (45.7%) of 407 patients had early HCC recurrence; the median time for early recurrence was 5.88 months. For the subgroups, 77 (49%) patients in Group A, 51 (47%) patients in Group B, and 58 (41%) patients in Group C were found to have early HCC recurrence. The difference is not statistically significant (p Z 0.385). The surgical margin is not considered as a risk factor ever for the early HCC recurrence. Table 3 showed that patient in various groups had similar patterns of HCC recurrence. It revealed that 87e89% of HCC recurrence occurred in intrahepatic parenchyma. No recurrence at surgical stump was found in any group. Most of intrahepatic recurrence (61.7e70.4%) was found at contralateral lobe of primary HCC. Tables 4 and 5 dispatched the predicted models for DFS and OS after hepatic resection, respectively. Multivariate Cox regression analysis was performed for these significant factors found in univariate analysis. Results of multivariate Cox regression analysis showed that lower levels of serum albumin, minor liver resection, and narrow surgical margin adversely influenced DFS after liver resection (p < 0.05) ( Table 4 ). On the other hand, prognostic factors for OS of HCC patients after hepatic resection were also analyzed. The results revealed that minor liver resection, postoperative complications, tumor numbers, HCC recurrence, lower levels of serum albumin, and portal vein invasion all significantly affected OS (p < 0.05) ( Table 5 ).
The KaplaneMeier method revealed both DFS and OS models among the three groups. The overall 1-, 3-, and 5-year DFS rates were, respectively, 61.5%, 32.4%, and 22.1% in Group A; 61.%, 44.9%, and 32.4% in Group B; and 64.5%, 49%, and 40.4% in Group C. Group C had higher DFS rate than Group A, and the difference was statistically significant (Group A vs. Group C, p Z 0.020) (Fig. 1A) . However, after controlling the independent risk factors for DFS, Cox regression model showed that there was no significant difference in no recurrence (Group A vs. Group B, p Z 0.364; Group A vs. Group C, p Z 0.062) (Fig. 1B) .
The overall 1-, 3-, and 5-year actual survival rates were, respectively, 88.4%, 63.2%, and 44.1% in Group A; 81.1%, 60.4%, and 47.3% in Group B; and 87.5%, 69%, and 54.4% in Group C. There was no significant difference among the three groups, (Group A vs. Group B, p Z 0.717; Group A vs. Group C, p Z 0.533; (Fig. 2A) . After controlling the independent risk factors for OS rate, multiple Cox regression models demonstrated that still no significant difference existed between groups (Group A vs. Group B, p Z 0.755; Group A vs. Group C, p Z 0.242) (Fig. 2B) . The results in multiple Cox regression model estimates revealed that there was no statistically significant difference between OS and DFS. Improved survival was seen in HCC patients with free surgical margins of liver resection, regardless of the width of the margins (all p > 0.05).
Discussion
Surgical resection is considered to be a curable treatment for HCC, which is eligible for surgery; however, the postoperative recurrence still poses a challenge to liver surgeons. Using a wide surgical margin to improve the surgical outcome is advocated by many investigators, 3, 5, 7, 8 but the clinical significance still remains controversial. The present study demonstrated that a liver resection with wider surgical margin (!10 mm) was not a significant factor associated with a better DFS and OS for resectable HCC. Matsue et al 6 demonstrated similar results that no margin seems to be the best procedure for patients with tumor close to the major hepatic vessels and with hepatic functions that do not permit wide-margin resections. The width of the resection margin did not influence the postoperative recurrence rates after hepatectomy for HCC. 7 The only effect of a wide surgical margin appeared to be the prevention of stump recurrence, which may be considered as a true local recurrence related to inadequate resection. The finding is not in accordance with the report from Wu et al, 9 which demonstrated that better outcome was found for early recurrence rate of HCC patients. The contradiction might be attributed to the heterogeneity of tumor characteristics, such as venous invasion (Wu's 71.5% vs. author's 21.4%), and grade III histologic grading (Wu's 23.4%
vs. author's 10.38%). By replacing 1-year cutoff with 2-year cutoff in the definition of early recurrence rate, which was adopted by Wu and associates, no statistical significance was found (results are not shown in this paper).
HCC recurrence is characterized by two unique histological features: intrahepatic spread and multicentric recurrence. Intrahepatic metastasis occurred mainly by means of portal venous spread and could occur anywhere in the liver remnant. In this study, patients in three groups have similar overall recurrent rates (58.97% vs. 54.13% vs. 48.5%, respectively, p Z 0.199), and almost all recurrences AJCC Z American Joint Committee on Cancer; CI Z confidence interval; HR Z hepatic resection; HCC Z hepatocellular carcinoma; HCV Z hepatitis C virus; OS Z overall survival; TNM Z tumor, lymph node, metastasis.
were found in the liver remnant. More than half of the recurrences were found in the contralateral lobe, indicating that recurrence is influenced by the width of surgical margin, and no recurrence was found at surgical stump, indicating that recurrence may originate from either intrahepatic metastasis or multicentric carcinogenesis;
thus, a wider resection margin is considered to have limited value. Poon et al 7 demonstrated that there was no significant difference between the patients with wider and narrow surgical margins in terms of intrahepatic recurrence. Most of the recurrent tumors were developed at a distal segment or multiple segments in both groups. Poon et al 10 advocated that the propensity of HCC to disseminate by means of portal venous system means that intrahepatic metastasis is likely to be present beyond 1 or 2 cm in most patients. Intrahepatic recurrence may also arise from multicentric carcinogenesis in the liver remnant, which also cannot be prevented by a wide surgical margin.
The risk factors for postoperative recurrence after resection of HCC have been studied extensively. They can be categorized into tumor, host, and surgical factors. 10 For the tumor factors, it is widely accepted that vascular invasion, satellite nodules, and tumor size are important mechanisms for intrahepatic metastasis. The TMN staging also provides an accurate prognostic classification of the long-term survival after resection of HCC.
Several tumor biologic factors such as DNA ploidy, 11 proliferating cell nuclear antigen index, 12 telomerase, 13 androgen receptor, 14 mutation of p53 gene, 15 and angiogenesis 16 are related to the growth and invasiveness of HCC. Metastatic tumor antigen 1 17, 18 is closely associated with microvascular invasion and poor survival in HCC patients. Micro-RNA (miRNA) may provide a similar profiling method to assist in identifying patients with HCC who are likely to develop a metastatic recurrence. 19, 20 Ezrin overexpression increased the risk of early recurrence. 21 Akt phosphorylation is a risk factor for early disease recurrence and poor prognosis in HCC. 22 Increased CD4 (þ) CD25 (þ) Fox P3(þ) Treg may impair the effect or function of CD8(þ) T cells, promoting disease progression. 23 For the host factors, HCC patients with hepatitis B virus (HBV) and hepatitis C virus (HCV) infection were attributed to a higher risk of HCC recurrence. Chuma et al 24 demonstrated that high serum HPV DNA levels and absence of antiviral therapy were independent risk factors for HCC recurrence. Patients with higher viral loads tended to have higher Ishak inflammatory and fibrosis scores than those with lower loads and associated with late recurrence. 9 Interferon therapy can improve postoperative outcomes in patients with HCV-related HCC by suppressing recurrence and preventing progress of cirrhosis, especially when interferon therapy has controlled their active hepatitis. 25 Due to the availability of data set, the above parameters were not included in the present paper. Therefore, the association could not be identified. To have a complete and comprehensive predictors of HCC patient survival research, the above parameters is suggested to be collected at prospective study design study.
The main surgical factors for HCC recurrence, such as the extent of resection, surgical margin, and perioperative transfusion, have also been examined widely. Although some investigators advocate that anatomic resection independently improves long-term survival 26 and achieves better DFS 27 in HCC patients, Kaibori et al 28 pointed out that anatomic resection did not provide any significant benefit in patients with HCV-associated HCC. Kuniya et al 29 also demonstrated that no superiority was seen in survival when HCC was treated by anatomic resection. Maintaining adequate liver function regardless of whether the resection is anatomic or not may be of greater importance. The severity of cirrhosis and tumor characteristics depicts longterm survival rather than the type of resection in HCC.
Blood transfusion is one of the independent risk factors that affect the DFS and OS in a multivariate analysis. 30e33 Katz et al 34 found that the magnitude of estimated blood loss during HCC resection is related to biologic characteristics of the tumor as well as to the extent of surgery. Increased intraoperative blood loss during HCC resection is an independent prognostic factor for HCC recurrence and death. Transfusion of blood product is associated with increased recurrence rate and worse survival after HCC surgery.
Postoperative complications can affect overall longterm survival after resection of HCC. Chok et al 35 using Cox proportional hazard model analysis revealed that the presence of postoperative complications can affect overall long-term survival after resection of HCC. Schiffiman et al 36 also demonstrated that treatment complication was one of the significant adverse factors for HCC resection.
In this study, more patients in Group C received extensive surgical resection compared to the other two groups (p < 0.001), to get a wider surgical margin. However, the patients in Group C have encountered heavy blood loss and needed blood transfusion (p Z 0.020) during liver resection. Excessive blood loss and blood transfusion are associated with a significantly higher postoperative complication rate in Group C patients (p Z 0.042). The finding is in accordance with the report from Chok et al. 35 Two out of 140 patients in Group C died within 30 days of liver resection, indicating a perioperative mortality rate of 1.4%; it is much higher than that of patients in Group A (0.64%) and Group B (0%), although it is not statistically significant. Therefore, it is obvious that no superiority was seen in patients with wider surgical margin in regard to perioperative outcomes.
The prognostic factors for DFS or OS after HCC resection have extensively been studied. Most authors 37e40 emphasized the important role of vascular invasion in HCC recurrence after surgery, although plenty of factors (such as preoperative liver function including elevation alkaline phosphatase value, elevated alanine transferase value, lower serum albumin, ChildePugh status; tumor characteristics including a-fetoprotein, tumor size, tumor number, presence of daughter nodules, tumor stage, and differentiation; and perioperative features including extent of surgery, surgical margin, and blood transfusion) are still regarded as independent risk factors for DFS and OS in multivariate analysis. Therefore, HCC recurrence after liver resection is associated with multiple factors, and not a single factor of resection margin. In the current study, we demonstrated that the patients in Group C had significantly higher DFS rate when compared to patients in Group A (p Z 0.02); however, it became insignificant (Group A vs. Group C, p Z 0.062) after controlling the independent risk factors. The information indicated that weak association existed for wide resection margin and survival rate. On the other hand, variables such as extent of resection and albumin were consistently significantly associated with both DFS and OS rates. This finding indicated that, in the long-term follow-up, resection margin is not an important risk factor for HCC recurrence as compared with others.
The present study identified that liver resection with a wide surgical margin was not a significant factor associated better DFS and OS for resectable HCC. A wide surgical margin for HCC is not an effective strategy for reducing the risk of postoperative recurrence. Most of the recurrences were related to intrahepatic metastasis or multicentric carcinogenesis, and hence could not be prevented by a wide surgical margin. In patients with limited liver function reserve, preservation of liver parenchyma should take priority over a wide surgical margin, and surgical margin should not be overemphasized to impact the surgical longterm outcome of HCC.
